Q5
LONG ANSWER
10M
★ High-yield
Define Approach to a Child with Anaemia. Describe its classification, investigations and management.
Definition
- Anaemia is a reduction in the haemoglobin concentration (or red-cell mass) below the normal range for age and sex.
- Because normal values change with age, an age-appropriate cut-off must be used (e.g. WHO: Hb < 11 g/dL at 6 months–5 years).
- A systematic approach identifies the cause efficiently.
Two Useful Classifications
Anaemia can be approached morphologically (by MCV) and kinetically (by mechanism):
Morphological Classification (BY MCV)
| Type | Examples |
|---|---|
| Microcytic (low MCV) | Iron deficiency, thalassaemia, anaemia of chronic disease, sideroblastic |
| Normocytic (normal MCV) | Haemolysis, acute blood loss, marrow failure/aplasia, chronic disease |
| Macrocytic (high MCV) | Megaloblastic (B12/folate), hypothyroidism, liver disease, aplastic anaemia |
Kinetic Classification (BY Mechanism)
- Decreased production — nutritional deficiency, marrow failure/infiltration, chronic disease.
- Increased destruction (haemolysis) — membrane, enzyme (G6PD), haemoglobin (thalassaemia, sickle) defects; immune haemolysis.
- Blood loss — acute or chronic.
The Reticulocyte Count (a Key Discriminator)
- High reticulocyte count → the marrow is responding → haemolysis or blood loss.
- Low reticulocyte count → a production defect (nutritional deficiency, marrow failure).
Clinical Evaluation
- History — diet, pica, blood loss, jaundice, drugs, family history (thalassaemia/haemolysis), age of onset, ethnicity.
- Examination — pallor, jaundice (haemolysis), hepatosplenomegaly and lymphadenopathy (haemolysis, leukaemia), bony changes, petechiae (marrow failure), koilonychia (IDA).
Investigations (stepwise)
- Haemogram with indices (MCV, MCH, RDW) and a peripheral smear — the essential first step.
- Reticulocyte count — to separate production from destruction/loss.
- Targeted tests — iron studies/ferritin (microcytic), HPLC (thalassaemia), B12/folate (macrocytic), Coombs test, G6PD, haemolysis markers (LDH, bilirubin) (haemolytic), and bone marrow (marrow failure/infiltration).
| Age | Hb (g/dL) |
|---|---|
| Newborn | 14–15 |
| 3 months (physiological nadir) | ~9.5–11 |
| 6 months–5 years | ≥ 11 |
| 6–12 years | ≥ 11.5 |
| Adolescent | ≥ 12 (girls) / ≥ 13 (boys) |
Peripheral Smear Clues
- Microcytic hypochromic + pencil cells → iron deficiency; target cells + basophilic stippling → thalassaemia.
- Macro-ovalocytes + hypersegmented neutrophils → megaloblastic; spherocytes → hereditary spherocytosis/immune haemolysis.
- Sickle cells → sickle disease; bite cells/Heinz bodies → G6PD deficiency; blasts → leukaemia.
Principle of Management
Management is directed at the specific cause identified — nutritional replacement, treatment of haemolysis/blood loss, or referral for marrow disease — rather than empirical transfusion, which is reserved for severe symptomatic anaemia.
Markers of Haemolysis
- Raised reticulocytes, unconjugated bilirubin and LDH; low haptoglobin.
- A positive direct Coombs test indicates immune haemolysis; blood-film morphology suggests the cause.
When to Refer
- Pancytopenia, blasts on the smear, or an unexplained non-nutritional anaemia.
- Suspected haemolysis, marrow failure or malignancy — for specialist evaluation and marrow study.
Key Principle
A logical, stepwise use of a few inexpensive tests (haemogram with indices, smear, reticulocyte count) identifies the mechanism in most children before committing to more expensive or invasive investigations.
Common Clinical Patterns (quick Recognition)
- Microcytic + low ferritin + high RDW → iron deficiency.
- Microcytic + normal ferritin + raised HbA2 → thalassaemia trait.
- Normocytic + high reticulocytes + jaundice → haemolysis.
- Macrocytic + hypersegmented neutrophils → megaloblastic anaemia.
- Pancytopenia → marrow failure or infiltration (needs marrow study).
All questions in Haematology & Oncology
- Q1Define Iron Deficiency Anaemia. Describe its aetiology, pathophysiology, clinical features and investigations. ★
- Q2Define Beta-Thalassaemia Major. Describe its pathophysiology, clinical features, investigations and management. ★
- Q3Define Acute Lymphoblastic Leukaemia. Describe its clinical features, investigations, management and prognosis. ★
- Q4Define Haemophilia. Describe its clinical features, investigations, management and complications. ★
- Q5Define Approach to a Child with Anaemia. Describe its classification, investigations and management. ★
- SN1Define Immune Thrombocytopenic Purpura. Describe its clinical features, investigations, diagnosis and management. ★
- SN2Define Sickle Cell Disease. Describe its clinical features, investigations, management and types. ★
- SN3Define Megaloblastic Anaemia. Describe its causes, clinical features, investigations and diagnosis.
- SN4Define Aplastic Anaemia. Describe its causes, clinical features, investigations and complications.
- SN5Define G6PD Deficiency. Describe its clinical features, investigations, pathophysiology and management.
- SN6Define Neuroblastoma. Describe its clinical features, investigations and prognosis.
- SN7Define Hodgkin Lymphoma. Describe its classification, aetiology, clinical features and investigations.